Rx00206 - Recombinant Human C1 Inhibitor


Name:
Recombinant Human C1 Inhibitor
Rx ID:
Rx00206
Validation Level:
Phenomic Similarity:
0.541
Reference ID:
FDA RB DB
Primary Indications:
Angioedema
Orphan Indications:
No annotated orphan indications.
Rare Indications:
Delayed graft function; solid organ transplantation; capillary leakage syndrome
Common Indications:
Acute abdominal attacks; acute facial attacks; hereditary angioedema
Drug Interactions:
No annotated drug interactions in DrugBank.
Food Interactions:
No annotated food interactions in DrugBank.

Interactive Drug Target Network

Interactive Bipartite Drug Repurposing Graph

Rx00206
Primary Indication
Secondary Indication

Disease prevalence from Electronic Health Records

Click row to show all

Disease A Disease B A∩B A∩¬B B∩¬A Odds-Ratio P-Value Adjusted P-Value
angioedema delayed graft function 22 2822 2697 11.663 1.98E-16 6.37e-13

Contact Us:
Please contact us if you have questions or comments about RepurposeDB. You can also contact us if you need help in submitting your drug repositioning investigation to RepurposeDB.


Dudley Laboratory
Department of Genetics and Genomic Sciences
Icahn Institute for Genomics and Multiscale Biology
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place, Box 1498
Manhattan, New York City, NY
repurposedb@dudleylab.org